375 related articles for article (PubMed ID: 10898684)
1. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
Tait-Kamradt A; Davies T; Cronan M; Jacobs MR; Appelbaum PC; Sutcliffe J
Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684
[TBL] [Abstract][Full Text] [Related]
2. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
[TBL] [Abstract][Full Text] [Related]
3. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.
Tait-Kamradt A; Davies T; Appelbaum PC; Depardieu F; Courvalin P; Petitpas J; Wondrack L; Walker A; Jacobs MR; Sutcliffe J
Antimicrob Agents Chemother; 2000 Dec; 44(12):3395-401. PubMed ID: 11083646
[TBL] [Abstract][Full Text] [Related]
4. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
[TBL] [Abstract][Full Text] [Related]
5. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
6. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
[TBL] [Abstract][Full Text] [Related]
7. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.
Pereyre S; Gonzalez P; De Barbeyrac B; Darnige A; Renaudin H; Charron A; Raherison S; Bébéar C; Bébéar CM
Antimicrob Agents Chemother; 2002 Oct; 46(10):3142-50. PubMed ID: 12234836
[TBL] [Abstract][Full Text] [Related]
8. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
Walsh F; Willcock J; Amyes S
J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
[TBL] [Abstract][Full Text] [Related]
9. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage.
Zhu H; Wang HP; Jiang Y; Hou SP; Liu YJ; Liu QZ
Andrologia; 2010 Aug; 42(4):274-80. PubMed ID: 20629652
[TBL] [Abstract][Full Text] [Related]
10. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
[TBL] [Abstract][Full Text] [Related]
11. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.
Pereyre S; Guyot C; Renaudin H; Charron A; Bébéar C; Bébéar CM
Antimicrob Agents Chemother; 2004 Feb; 48(2):460-5. PubMed ID: 14742195
[TBL] [Abstract][Full Text] [Related]
12. Identification of A2059G 23S rRNA and G439A rplC gene mutations in Streptococcus criceti strain OMZ 61, a strain resistant to azithromycin, josamycin and clindamycin.
Tamura H; Yamada A; Kato H
Genes Genet Syst; 2015; 90(5):259-67. PubMed ID: 26725523
[TBL] [Abstract][Full Text] [Related]
13. Induction of macrolide resistance in Mycoplasma gallisepticum in vitro and its resistance-related mutations within domain V of 23S rRNA.
Wu CM; Wu H; Ning Y; Wang J; Du X; Shen J
FEMS Microbiol Lett; 2005 Jun; 247(2):199-205. PubMed ID: 15936901
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.
Sugiyama H; Yoshida I; Ueki M; Tanabe K; Manaka A; Hiramatsu K
J Antibiot (Tokyo); 2017 Mar; 70(3):264-271. PubMed ID: 28074049
[TBL] [Abstract][Full Text] [Related]
15. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
Reinert RR; Al-Lahham A
Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
[TBL] [Abstract][Full Text] [Related]
16. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
[TBL] [Abstract][Full Text] [Related]
17. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics.
Pereyre S; Métifiot M; Cazanave C; Renaudin H; Charron A; Bébéar C; Bébéar CM
Int J Antimicrob Agents; 2007 Feb; 29(2):207-11. PubMed ID: 17196370
[TBL] [Abstract][Full Text] [Related]
19. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations.
Malbruny B; Nagai K; Coquemont M; Bozdogan B; Andrasevic AT; Hupkova H; Leclercq R; Appelbaum PC
J Antimicrob Chemother; 2002 Jun; 49(6):935-9. PubMed ID: 12039885
[TBL] [Abstract][Full Text] [Related]
20. Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000.
Davies TA; Bush K; Sahm D; Evangelista A
Antimicrob Agents Chemother; 2005 Jul; 49(7):3031-3. PubMed ID: 15980393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
